ストックスクリーナーアプリを入手
7.65
5.20%
-0.42
Fibrogen Inc (FGEN) 最新ニュース
Is FibroGen Inc. a good long term investmentFree Real-Time Stock Data - jammulinksnews.com
What analysts say about FibroGen Inc. stockConsistent triple returns - jammulinksnews.com
What drives FibroGen Inc. stock priceOutstanding capital appreciation - jammulinksnews.com
Why FibroGen Inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - beatles.ru
What makes FibroGen Inc. stock price move sharplyFree Investment Community - Newser
How FibroGen Inc. stock performs during market volatilityParabolic Move Ideas - Newser
FibroGen amends financing agreement to reduce minimum cash balance requirement By Investing.com - Investing.com South Africa
FibroGen amends financing agreement to reduce minimum cash balance requirement - Investing.com Australia
FibroGen (FGEN) Trading Halted Pending News Release | FGEN Stock News - GuruFocus
FibroGen Enters New Agreement with HiFiBiO - TipRanks
Fibrogen IncOn June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio - MarketScreener
FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split | FGEN St - GuruFocus
FibroGen to implement 1-for-25 reverse stock split; shares down 15% - MSN
Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Adobe, RH And 3 Stocks To Watch Heading Into FridayAdobe (NASDAQ:ADBE), FibroGen (NASDAQ:FGEN) - Benzinga
FibroGen Announces 1-for-25 Reverse Stock Split | FGEN Stock New - GuruFocus
FibroGen Announces Reverse Stock Split Effective June 16 - TipRanks
FibroGen to Implement 1-for-25 Reverse Stock Split - marketscreener.com
FibroGen To Implement 1-for-25 Reverse Stock Split - Nasdaq
FibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025 - Nasdaq
Fibrogen Announces 1-For-25 Reverse Stock Split - marketscreener.com
FibroGen Announces 1-for-25 Reverse Stock Split - GlobeNewswire
FibroGen's Massive 1-for-25 Reverse Split Cuts 101M Shares to 4MWhat Investors Must Know - Stock Titan
Millennium Management LLC Lowers Stock Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - The Manila Times
FibroGen expands board with biotech veteran Kauffman By Investing.com - Investing.com South Africa
FibroGen expands board with biotech veteran Kauffman - Investing.com Australia
FibroGen Amends Financing Agreement for Flexibility - TipRanks
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors | FGEN Stock News - GuruFocus
Fibrogen Appoints Michael Kauffman To Its Board Of Directors - marketscreener.com
FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan
Squarepoint Ops LLC Takes Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Two Sigma Advisers LP Has $465,000 Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
FibroGen, Inc. (NASDAQ:FGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com - Defense World
FibroGen outlines $185M China divestiture and extended cash runway into 2027 while advancing prostate cancer pipeline - MSN
FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline By Investing.com - Investing.com South Africa
FibroGen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
FibroGen Q1 2025 slides: China sale to extend cash runway amid revenue decline - Investing.com Australia
HC Wainwright Has Negative Outlook for FibroGen Q2 Earnings - Defense World
FibroGen’s Earnings Call: Strategic Gains Amid Revenue Woes - TipRanks
FibroGen (NASDAQ:FGEN) Earns Buy Rating from HC Wainwright - Defense World
FibroGen (FGEN) Boosts Sale Proceeds from Chinese Division - GuruFocus
0.59%
0.34%
大文字化:
|
ボリューム (24 時間):